| Net Cash Provided by (Used in) Operating Activities |
$12,731,000 |
USD |
225% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$61,237,000 |
USD |
217% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$20,112,000 |
USD |
37% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
16,456,563 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$53,856,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$50,546,000 |
USD |
69% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$6,953,000 |
USD |
5.8% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$317,445,000 |
USD |
-25% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$318,509,000 |
USD |
-25% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$490,000 |
USD |
-55% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
$517,000 |
USD |
-57% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$730,000 |
USD |
40% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$86,000 |
USD |
-80% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$431,000 |
USD |
-37% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.12 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$27,000 |
USD |
-78% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$188,971,000 |
USD |
9.5% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$254,539,000 |
USD |
-14% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,064,000 |
USD |
-3.4% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$27,983,000 |
USD |
6.5% |
Q3 2025 |
Q3 2025 |